Key Statistics
Market Cap$6.71B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$4.07
52W High$114.94
52W Low$47.86
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees209
Price Performance
1 Week+0.17%
3 Month+85.62%
1 Year+83.81%
FinancialsAnnual · QuiverQuant
Revenue$110.32M
Assets$825.13M
Liabilities$339.75M
Net Income$70.69M loss
About
Arcellx, Inc., a clinical-stage biotechnology company, is engaged in the development of various immunotherapies for patients with cancer and other incurable diseases. The company is headquartered in Gaithersburg, Maryland.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze ACLX with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.